Related Experiment Video
Updated: May 12, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Serotonergic drugs for depression and beyond.
Stephen M Stahl1, Clara Lee-Zimmerman, Sylvia Cartwright
1Neuroscience Education Institute, 1930 Palomar Point Way, Carlsbad, CA 92008, USA. smstahl@neiglobal.com
Current Drug Targets
|March 28, 2013
Summary
Current antidepressants primarily target serotonin transporters (SERT). Newer drugs combine SERT inhibition with other mechanisms to improve depression treatment and reduce side effects like sexual dysfunction.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Current antidepressants largely target the serotonin transporter (SERT).
- Early selective serotonin reuptake inhibitors (SSRIs) have evolved into combination therapies.
- Newer strategies involve multi-acting drugs for enhanced efficacy and tolerability.
Purpose of the Study:
- To review the evolution of antidepressant drug development beyond simple SERT inhibition.
- To highlight novel antidepressant mechanisms and their therapeutic potential.
- To discuss strategies for addressing residual depressive symptoms and side effects.
Main Methods:
- Review of pharmacological mechanisms of existing and developing antidepressants.
- Analysis of combination therapies and multi-acting single molecules.
- Examination of drug actions at various receptor and transporter targets.
Main Results:
- Antidepressant development has progressed from selective SERT inhibition to complex multimodal approaches.
- Drugs like SNRIs, bupropion, trazodone, mirtazapine, buspirone, and atypical antipsychotics exhibit diverse mechanisms.
- Novel agents like vilazodone, triple reuptake inhibitors, and vortioxetine integrate multiple actions, including SERT inhibition.
Conclusions:
- Combining SERT inhibition with other mechanisms offers promising new avenues for depression treatment.
- Multimodal antidepressants may target residual symptoms and mitigate side effects, such as sexual dysfunction.
- Future research focuses on developing sophisticated drugs with tailored pharmacological profiles for depression.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.